iShares MSCI Dow Jones US Pharmaceuticals - IHE

Yahoo! Finance: IHE News

Latest Financial News for iShares iShares Dow Jones U.S.

• Emerging Markets to Drive Health Care ETFs

  (Thu, 26 Aug 2010 18:50:00 GMT)

• Emerging Market GDP Growth Should Drive Healthcare ETFs

  (Thu, 26 Aug 2010 18:45:01 GMT)

• Investing For The Diabetes Epidemic

  (Fri, 30 Jul 2010 17:26:15 GMT)

• [$$] Spread Your Risk in the Pharma Sector

  (Fri, 30 Jul 2010 14:35:53 GMT)

• Three ETFs to Play Pharma

  (Wed, 21 Jul 2010 16:05:21 GMT)

• [$$] Life After Reform

  (Tue, 20 Jul 2010 13:37:05 GMT)

• ETFs to Play a U.S. Export Boom

  (Thu, 08 Jul 2010 14:09:48 GMT)

• ETFs to Play the U.S. Export Boom

  (Wed, 07 Jul 2010 19:39:37 GMT)

• [$$] ETFs for Your Health Care Portfolio

  (Tue, 04 May 2010 14:03:29 GMT)

• Six ETFs to Watch This Week

  (Mon, 03 May 2010 10:02:25 GMT)

Yahoo! Finance: RSS feed not found

Yahoo! Finance: RSS feed not found

• Yahoo! Finance: RSS feed not found

  ()

  RSS feed not found. Please remove this RSS feed or check Yahoo! Finance for more symbols.

MSN Money News - IHE

News about iShares Dow Jones US Pharmaceuticals

IHE - News and Analysis from Seeking Alpha

'IHE' Tag RSS Syndication from SeekingAlpha.com

• Pharma ETFs: Next Up, Emerging Markets

  (Tue, 31 Aug 2010 10:51:45 -0400)

  Tom Lydon submits:

  Citizens of developing countries are getting richer. That newfound wealth is a major opportunity for health care ETFs, and that fact hasn’t been lost on big pharma.

  As the emerging market middle class grows, so will health care resources and companies. Kevin Grewal for Seeking Alpha reports that a report released by UBS indicates that developing nations are expected to account for $550 billion of annual drug sales per year by 2020. This may account for more than 70% of all drug sales growth and pushing China and Brazil ahead of France, England and Germany when...

• Emerging Market GDP Growth Should Drive Healthcare ETFs

  (Thu, 26 Aug 2010 14:45:01 -0400)

  Kevin Grewal submits:

  As emerging markets continue to grow and affluence rises, the developing world is likely to be the driving force behind growth in the global health care sector, paving the path to opportunity in the iShares S&P Global Healthcare Sector Index Fund (IXJ), the iShares Dow Jones US Pharmaceuticals Index Fund (IHE) and the Vanguard Health Care ETF (VHT).

  A report...

• A Changing Pharma Landscape: Three ETFs Covering the Sector

  (Fri, 06 Aug 2010 16:19:00 -0400)

  Tom Lydon submits:

  Big pharma companies are looking at a changing landscape, not least of which is the fact that many blockbuster drugs are about to lose their patents, opening the doors for generic players. The increased competition may be a boon to pharma ETFs.

  Executives at big pharmaceutical companies are not sitting idle. They’re hard at work, partnering with companies to come up with the latest and greatest as the patents on more popular drugs near expiration. Marc Litchfield for Investment U reports that many pharmaceutical companies and biotech companies...

• ETFs to Play the U.S. Export Boom

  (Wed, 07 Jul 2010 15:39:37 -0400)

  Michael Johnston submits:

  The first year and a half of president Obama’s term has been market by bold initiatives to reshape domestic policies and transform the U.S. economy. And for the most part the administration has followed through on its promises, already pushing through overhauls of the health care and financial systems. During his January State of the Union Address, Obama announced his National Export Initiative, a plan to double the country’s exports within five years. By boosting the value of American goods shipped overseas the president hopes to create new jobs on the home front, overcoming one of the...

• Unemployment Claims Rise, ETFs Fall

  (Thu, 17 Jun 2010 12:17:53 -0400)

  Tom Lydon submits:

  While shoppers got a break last month in slightly lower prices, the markets and exchange traded funds were far less enthused about yet another sharp increase in claims for unemployment benefits.

  First-time claims for jobless benefits shot up by 12,000 to the highest level in a month. The four-week average for unemployment claims did dip slightly, but continued weakness in the unemployment real has kept real economic recovery at bay. Economists are concerned with how long it’s taking to see these numbers fall below certain levels.

  
  Complete Story »

• HOLDRs Still Popular Like It's the Year 2000: Time for a Change?

  (Tue, 01 Jun 2010 05:28:50 -0400)

  Street One Financial submits:

  by Paul Weisbruch
  
  The Merrill Lynch HOLDRs lineup of funds is well known in the ETF industry and has been around since 2000. They carry name recognition and many investors and portfolio managers, especially those in the institutional and hedge fund space. SMH and OIH, and at one time HHH, were familiar monikers on sell side trading desks as well as those of buy side managers. The HOLDRs suite of products still retains a respectable amount of assets as...

• Abbott Expands Emerging Market Generic Drug Presence with Piramal Acquisition

  (Sun, 23 May 2010 03:58:47 -0400)

  Mike Havrilla submits:

  Abbott Labs (NYSE:ABT) is poised to become the top pharmaceutical company in India, following its acquisition of Piramal's healthcare solutions business. The deal follows a collaboration announced last week between Abbott and India-based Zydus Cadila. Abbott also announced the establishment of a stand-alone established products division which accounts for over $5 billion in sales. The established products division consists of branded generics, which represent off-patent products subject to generic competition that are able to retain many of the characteristics of proprietary pharmaceutical products - especially in emerging markets such as India.

• Beyond XLV: Five Alternative Healthcare ETFs

  (Tue, 18 May 2010 12:19:30 -0400)

  Michael Johnston submits:

  Healthcare was once considered to be one of the most stable sectors of the US economy, with demands for products and services fluctuating little during various phases of the economic cycle. But recent events in Washington have brought increased scrutiny and volatility, as the Obama administration’s healthcare reform has investors questioning the future of healthcare ETFs. Many of the long-term impacts of reform are still unknown. The bill will most certainly have an impact on healthcare insurance issuers; nearly 30 million new customers could translate into more revenue. But companies...

• Canceled Trades From the May 6 'Flash Crash'

  (Sun, 16 May 2010 08:48:59 -0400)

  Morningstar submits:

  By Paul Justice

  click to enlarge

  

  
  Complete Story »

• Pharma ETFs: The Bulls May Prevail

  (Fri, 14 May 2010 07:12:14 -0400)

  Tom Lydon submits:

  Wouldn’t it be nice to know exactly how the health care bill will affect pharmaceutical companies? Since we don’t, let’s take a look at the state of the biomedical sector and how related ETFs may perform.

  Industry executives are sending mixed signals, reports Carol Kopp of Minyanville. On the one hand, they are making a ruckus about how the newly minted health care bill will take a huge chunk out of future earnings. Bristol-Myers Squibb said that 2010 earnings will be cut by $0.12 a share, or $300 to $400 million in revenue.
  

  
  

News for iShares Dow Jones US Pharm Indx (ETF) - Google Finance

News for iShares Dow Jones US Pharm Indx (ETF) - Google Finance

• Emerging Markets To Drive Healthcare ETFs (IXJ, IHE, VHT, UBS, LLY, ABT)

  (Thu, 26 Aug 2010 22:11:22 GMT)
  Emerging Markets To Drive Healthcare ETFs (IXJ, IHE, VHT, UBS, LLY, ABT)
  ETF Daily News - Aug 26, 2010

  As emerging markets continue to grow and affluence rises, the developing world is likely to be the driving force behind growth in the global health care sector paving the path to opportunity in ...

• Life After Reform

  (Tue, 20 Jul 2010 13:39:09 GMT)
  Life After Reform
  TheStreet.com - Jul 20, 2010

  By Don Dion The 82% slide in Goldman Sachs' (GS - commentary - Trade Now) earnings in the second quarter -- announced today -- will certainly give investors something to think about when measuring ...

Only registered users can write comments.
Please login or register.